Login / Signup

Diagnosis of hyperprolactinemia in women: A Position Statement from the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the Brazilian Society of Endocrinology and Metabolism (SBEM).

Andrea GlezerHeraldo Mendes GarmesLeandro KasukiManoel MartinsPaula Condé Lamparelli EliasVania Dos Santos Nunes NogueiraAna Carolina Japur de Sá Rosa-E-SilvaGustavo Arantes Rosa MacielCristina Laguna Benetti-PintoAndrea Prestes Nácul
Published in: Archives of endocrinology and metabolism (2024)
Hyperprolactinemia is a frequent cause of menstrual irregularity, galactorrhea, hypogonadism, and infertility. The most common etiologies of hyperprolactinemia can be classified as physiological, pharmacological, and pathological. Among pathological conditions, it is essential to distinguish prolactinomas from other tumors and pituitary lesions presenting with hyperprolactinemia due to pituitary stalk disconnection. Proper investigation considering clinical data, laboratory tests, and, if necessary, imaging evaluation, is important to identify the correctcause of hyperprolactinemia and manage the patient properly. This position statement by the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and Brazilian Societyof Endocrinology and Metabolism (SBEM) addresses the recommendations for measurement of serum prolactin levels and the investigations of symptomatic and asymptomatic hyperprolactinemia and medication-induced hyperprolactinemia in women.
Keyphrases
  • polycystic ovary syndrome
  • healthcare
  • high resolution
  • emergency department
  • big data
  • type diabetes
  • growth hormone
  • oxidative stress
  • electronic health record
  • artificial intelligence
  • stress induced